Skip to main content
Equibles
OHI logo

OHI · Omega Healthcare Investors Inc

Track OHI — free

Use OHI with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$46.99 +0.20 (+0.43%)
S&P 400 member Russell 1000 member Rebalance outlook locked
Market Cap
$14.18B
Shares
303.01M

OHI metrics

73 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$46.79
Market cap
$14.18B

Price action

19 metrics
Price change (1W)
-0.3%
Price change (30D)
-4.5%
Price change (3M)
+4.4%
Price change (6M)
-1.4%
Price change (YTD)
+5.5%
Price change (1Y)
+9.9%
Trailing year
Price change (5Y)
+38.5%
52-week high
$51.72
52-week low
$39.41
Change from 52-week high
-9.5%
Change from 52-week low
+18.7%
Annualized volatility
21.0%
Beta
-0.3
RSI (14D)
45.9
Price vs SMA 50
-3.1%
Price vs SMA 200
+1.0%
Avg volume (3M)
2.05M
Relative volume
0.9
Average dollar volume
$96.85M

Company

3 metrics
Sector
Real Estate
Industry
REIT - Healthcare Facilities
Shares outstanding
303.01M

Valuation

12 metrics
P / E (TTM)
16.7
Trailing earnings · reciprocal yield 6.0%
PEG ratio
0.1
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
11.1×
reciprocal yield 9.0%
P / book
2.6
reciprocal yield 38.0%
FCF yield
—
TTM · current market cap
Buyback yield
1.0%
P / FCF
—
P / operating cash flow
15.9
reciprocal yield 6.3%
Earnings yield
6.1%

Historical valuation

8 metrics
P / E historical average (3Y)
26.1×
reciprocal yield 3.8%
P / E historical average (5Y)
25.5×
reciprocal yield 3.9%
EV / revenue historical average (3Y)
14.3×
reciprocal yield 7.0%
EV / revenue historical average (5Y)
13.7×
reciprocal yield 7.3%
EV / EBIT historical average (3Y)
26.8×
reciprocal yield 3.7%
EV / EBIT historical average (5Y)
26.8×
reciprocal yield 3.7%
EV / EBITDA historical average (3Y)
15.9×
reciprocal yield 6.3%
EV / EBITDA historical average (5Y)
15.9×
reciprocal yield 6.3%

Dividends & buybacks

7 metrics
Dividend yield
5.7%
Trailing 12 months
Payout ratio
92.6%
Shareholder yield
—
Dividend / share (TTM)
$2.69
Dividend growth YoY
+0.4%
Dividend growth streak
—
Last ex-dividend
2026-08-03

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-30

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
67.0%
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
$858.43M
Trailing 12 months
Diluted EPS (TTM)
$2.81
FCF margin
—
Effective tax rate
1.8%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$17.60

Growth

11 metrics
Revenue growth YoY
+16.2%
Year over year
Net income growth YoY
+165.6%
Revenue (TTM)
$1.28B
Trailing 12 months
EPS growth YoY
+158.7%
Shares change YoY
+4.3%
Year over year · more shares
Revenue CAGR (3Y)
+10.7%
Revenue CAGR (5Y)
+5.9%
EPS CAGR (3Y)
+2.5%
EPS CAGR (5Y)
+22.6%
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
15.9%
Return on assets
8.6%
Debt / equity
—
Current ratio
—
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$39.04M
Total assets
$10.01B
Total debt
$4.26B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$890.56M
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$53.19M
R&D / revenue
—
Stock compensation / revenue
4.1%

Ownership (13F)

3 metrics
13F filers
762
13F filer change QoQ
+9
Institutional ownership
82.2%

Short interest

3 metrics
Short interest
4.0%
Latest settlement · 6.8 days to cover
Days to cover
6.8d
Short-squeeze score
56 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 888491 CUSIP 681936100 13F (30d) 492 filings 465 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)